|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002645,
umls-concept:C0010622,
umls-concept:C0010798,
umls-concept:C0017431,
umls-concept:C0050940,
umls-concept:C0055856,
umls-concept:C0079488,
umls-concept:C0080103,
umls-concept:C0087111,
umls-concept:C0205174,
umls-concept:C0376622,
umls-concept:C0796517,
umls-concept:C0850666,
umls-concept:C1280500,
umls-concept:C1521828,
umls-concept:C1552137,
umls-concept:C1704939,
umls-concept:C1823242,
umls-concept:C1880198,
umls-concept:C1882417
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-8-16
|
|
pubmed:abstractText |
Polymorphism in MDR1 is associated with variation in the plasma level of a proton pump inhibitor.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
pubmed-author:FurutaTT,
pubmed-author:HishidaAA,
pubmed-author:IkumaMM,
pubmed-author:IshizakiTT,
pubmed-author:KodairaCC,
pubmed-author:KumagaiJJ,
pubmed-author:MatsushitaFF,
pubmed-author:NakajimaHH,
pubmed-author:NishinoMM,
pubmed-author:SenolNN,
pubmed-author:ShiralAA,
pubmed-author:SugimotoMM,
pubmed-author:UmemuraKK,
pubmed-author:WatanabeHH,
pubmed-author:YamadaII
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
693-703
|
|
pubmed:meshHeading |
pubmed-meshheading:17697203-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:17697203-Amoxicillin,
pubmed-meshheading:17697203-Anti-Bacterial Agents,
pubmed-meshheading:17697203-Anti-Ulcer Agents,
pubmed-meshheading:17697203-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:17697203-Clarithromycin,
pubmed-meshheading:17697203-Drug Therapy, Combination,
pubmed-meshheading:17697203-Female,
pubmed-meshheading:17697203-Genotype,
pubmed-meshheading:17697203-Helicobacter Infections,
pubmed-meshheading:17697203-Helicobacter pylori,
pubmed-meshheading:17697203-Humans,
pubmed-meshheading:17697203-Male,
pubmed-meshheading:17697203-Middle Aged,
pubmed-meshheading:17697203-Mixed Function Oxygenases,
pubmed-meshheading:17697203-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:17697203-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.
|
|
pubmed:affiliation |
Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Japan. furuta@hama-med.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
